2011
Alkek Awardees for Pilot Projects in Experimental Therapeutics
Investigator's Name
|
Department & Section
|
Project Title
|
Chen, Johnny, MD
|
Surgery
|
miR-196a Antagomirs: Novel Therapeutic Agents for Pancreatic Cancer
|
Cooper, Thomas, MD
|
Pathology/Immunology
|
Antisense oligonucleotide therapy for myotonic dystrophy
|
Lacorazza, Daniel, PhD
|
Pathology/Immunology
|
Pre-clinical evaluation of sulforaphane in acute lymphoblastic leukemias
|
Li, De-Quan, MD, PhD
|
Opthamology
|
GDNF as a novel non-corticosteroid anti-inflamatory agent for ocular inflammatory disease
|
Lonard, David, PhD
|
Molecular and Cell Biology
|
Pre-clinical evaluation of bifunctional small hairpin RNAs against steroid receptor coactivator 3/amplified in breast cancer 1 (SRC-3) in tamoxifen and anti-HER2 resistant breast cancers
|
Lu, Jian-Ming
|
Surgery
|
Development of a Xanthine Oxidase Inhibitor from Natural Substances for Gout Therapy
|
Matzuk, Martin, MD, PhD
|
Pathology/Immunology
|
Identification of male contraceptives that target spermatogenesis-specific protein BRDT
|
Olmsted-Davis, Elizabeth, PhD
|
Hematology/Oncology - CAGT
|
Injection of osteoinductive microspheres for rapid repair of long bone injuries
|
Song, Yongcheng, PhD
|
Pharmacology
|
Novel Histone Methyltransferase Inhibitors Targeting Leukemic Stem Cells
|
Tweardy, David, MD
|
Medicine - Infectious Disease
|
Combining Stat3 inhibition and T-cell immunotherapy as a novel treatment for glioblastoma multiforme
|
Wehrens, Xander, MD, PhD
|
Physiology
|
Developing novel ryanodine receptor blockers for the treatment of heart failure and cardiac arrhythmias
|
Weigel, Nancy, PhD
|
Molecular and Cell Biology
|
A new therapeutic approach to eliminate androgen receptor signaling in prostate cancer
|
Weisman, Leonard, MD
|
Pediatrics - Neonatology
|
Development of a ureaplasma DNA vaccine for the prevention and treatment of human infection
|
Yao, Cathy, MD
|
Surgery
|
Mesothelin-Virus Like Particle: Novel Therapeutic Vaccine for Pancreatic Cancer
|
Yu-Lee, Li-Yuan, PhD
|
Medicine
|
Targeting Plk1 with a small molecule inhibitor for castration- resistant prostate cancer
|
|